Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors Free

Abstract

Expression from a short human cytomegalovirus (HCMV) major immediate early (IE) promoter- enhancer was tested in three different virus vectors: recombinant adenovirus (Ad), recombinant herpes simplex virus type 1 (HSV-1) and HSV-1-derived amplicon vectors. The HCMV major IE promoter- enhancer within a replication-deficient recombinant Ad vector was shown to produce cell-specific expression in rat nervous system cell cultures. Recombinant Ad entered all cell types examined but the HCMV major IE promoter was silent in primary cultures of neocortical neurons and Schwann cells, although it drove transgene expression in astrocytes and fibroblasts. Moreover, in neurons and Schwann cells, expression from the HCMV major IE promoter-enhancer in the replication-deficient Ad vector was activated by superinfection with HSV-1, replication-competent Ad and HCMV. The HCMV major IE promoter-enhancer was active in neurons when inserted into HSV-1 recombinant vectors. Further experiments with HSV-1-derived amplicons strongly suggested that an IE protein was responsible for the activation of HCMV major IE-induced expression in neurons. This demonstrates that the activity of the HCMV major IE promoter-enhancer element can depend on the expression of other genes encoded in the virus vector backbone within which it is inserted, and that it can function in a neuronal cell type-specific manner when inserted into a replication-deficient Ad vector.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-2-445
1997-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/2/9018068.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-2-445&mimeType=html&fmt=ahah

References

  1. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L. D., Poenaru L., Perricaudet M., Kahn A., Peschanski M. R. 1993; Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3:224–228
    [Google Scholar]
  2. Akrigg A., Wilkinson G. W. G., Oram J. D. 1985; The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Research 2:107–121
    [Google Scholar]
  3. Babiss L. E., Friedman J. M., Darnell J. E.Jr 1986; Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Molecular and Cellular Biology 6:3789–3806
    [Google Scholar]
  4. Bajocchi G., Feldman S. H., Crystal R. G., Mastrangeli A. 1993; Direct in vitro gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genetics 3:229–234
    [Google Scholar]
  5. Banker G., Goslin K. 1991 Culturing Nerve Cells pp. 453 Cambridge, MA: MIT Press;
    [Google Scholar]
  6. Baskar J. F., Smith P. P., Nilaver G., Jupp R. A., Hoffman S., Peffer N. J., Tenney D. J., Colberg Poley A. M., Ghazal P., Nelson J. A. 1996; The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell-type-specific expression in transgenic mice. Journal of Virology 70:3207–3214
    [Google Scholar]
  7. Besserau J. L., Stratford-Perricaudet L. D., Piette J., le Poupon C., Changeux J. C. 1994; In vivo and in vitro analysis of electrical activity dependent expression of muscle acetylcholine receptor genes using adenovirus. Proceedings of the National Academy of Sciences, USA 91:1304–1308
    [Google Scholar]
  8. Boshart M., Weber F., Gerhard J., Dorsch-Hasler K., Fleckenstein B., Schaffner W. 1985; A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
    [Google Scholar]
  9. Byrnes A. P., Rusby J. E., Wood M. J. A., Charlton H. M. 1995; Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015–1024
    [Google Scholar]
  10. Byrnes A. P., Maclaren R. E., Charlton H. M. 1996; Immunological instability of persistent adenovirus vectors in the brain - peripheral exposure to vector leads to renewed inflammation, reduced gene- expression, and demyelination. Journal of Neuroscience 16:3045–3055
    [Google Scholar]
  11. Cockett M. I., Bebbington C. R., Yarranton G. T. 1991; The use of engineered E1a genes to transactivate the hCMV-MIE promoter in permanent CHO cell line. Nucleic Acids Research 19:319–325
    [Google Scholar]
  12. Davidson B. L., Allen E. D., Kozarsky K. F., Wilson J. M., Roessler B. J. 1993; A model system for in vitro gene transfer into the central nervous system using an adenoviral vector. Nature Genetics 3:219–223
    [Google Scholar]
  13. DeLuca N. A., McCarthy A., Schaffer P. A. 1985; Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulation protein ICP4. Journal of Virology 56:558–570
    [Google Scholar]
  14. Engelhardt J. F., Ye X., Doranz B., Wilson J. M. 1994; Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse. Proceedings of the National Academy of Sciences, USA 91:6196–6200
    [Google Scholar]
  15. Fisher K. J., Choi H., Burda J., Chen S. J., Wilson J. M. 1996; Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11–22
    [Google Scholar]
  16. Gorman C. M., Gies D., McCray G., Huang M. 1989; The human cytomegalovirus major immediate early promoter can be transactivated by adenovirus early protein. Virology 171:377–385
    [Google Scholar]
  17. Grubb B. R., Pickles R. J., Ye H., Yankaskas J. R., Vick R. N., Engelhardt J. F., Wilson J. M., Johnson L. G., Boucher R. C. 1994; Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371:802–806
    [Google Scholar]
  18. Hayashi Y., DePaoli A. M., Burant C. F., Refetoff S. 1994; Expression of a thyroid hormone responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. Journal of Biological Chemistry 269:23872–23875
    [Google Scholar]
  19. Imperiale M. J., Kao H. T., Feldman L. T., Nevins J. R., Strickland S. 1984; Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Molecular and Cellular Biology 4:867–874
    [Google Scholar]
  20. Jeang K. T., Rawlins D. R., Rosenfield P. J., Shero J. H., Kelly T. J., Hayward G. S. 1987; Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. Journal of Virology 61:1559–1570
    [Google Scholar]
  21. Kaplitt M. G., Kwong A. D., Kleopoulos S. P., Mobb C. V., Rabkin S. D., Pfaff D. W. 1994; Preproenkephalin promoter yields region specific and long term expression in adult brain after direct in vitro gene transfer via a defective herpes simplex viral vector. Proceedings of the National Academy of Sciences, USA 91:8979–8983
    [Google Scholar]
  22. Kass-Eisler A., Falck-Pedersen E., Elfenbein D. H., Alvira M., Butrick P. M., Leinwand L. A. 1994; The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1:395–402
    [Google Scholar]
  23. Koedood M., Fichtel A., Meier P., Mitchell P. J. 1995; Human cytomegalovirus immediate early enhancer promoter specificity during embryogenesis defines target tissues of congenital CMV infection. Journal of Virology 69:2194–2207
    [Google Scholar]
  24. Kothari S., Baillier J., Sissons J. G. P., Sinclair J. H. 1991; The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Research 19:1767–1771
    [Google Scholar]
  25. Le Gal La Salle G., Robert J. J., Berard S., Ridoux V., Stratford-Perricaudet L. D., Perricaudet M., Mallet J. 1993; Adenovirus as a potent vector for gene transfer in neurons and glia in the brain. Science 259:988–990
    [Google Scholar]
  26. Liu B., Stinski M. F. 1992; Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. Journal of Virology 66:4434–4444
    [Google Scholar]
  27. Liu R., Baillie J., Sissons J. G. P., Sinclair J. H. 1994; The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Research 22:2453–2459
    [Google Scholar]
  28. Lowenstein P. R., Fournel S., Bain D., Tomasec P., Clissold P. M., Castro M. G., Epstein A. L. 1994a; Herpes simplex virus 1 (HSV1) helper co-infection affects the distribution of an amplicon encoded protein in glia. Neuroreport 5:1625–1630
    [Google Scholar]
  29. Lowenstein P. R., Morrison E. E., Bain D., Hodge P., Preston C. M., Clissold P., Stow N. D., McKee T. A., Castro M. G. 1994b; Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression oftransgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro. Neuroscience 60:1059–1077
    [Google Scholar]
  30. Lowenstein P. R., Fournel S., Bain D., Tomasec P., Clissold P. M., Castro M. G., Epstein A. L. 1995; Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. Molecular Brain Research 30:169–175
    [Google Scholar]
  31. Lubon H., Ghazal P., Henninghausen L., Reynolds-Kohler C., Lockshin C., Nelson J. 1989; Cell specific activity of the modulator region in the human cytomegalovirus major immediate early gene. Molecular and Cellular Biology 9:1342–1345
    [Google Scholar]
  32. McGrory W. J., Bautisita D. S., Graham F. L. 1988; A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163:614–617
    [Google Scholar]
  33. Morgan L. 1996; Schwann cell culture. In Neural Cell Culture. A Practical Approach pp. 221–237 Cohen J., Wilkinson G. Edited by Oxford: IRL Press;
    [Google Scholar]
  34. Olive D. M., al-Mulla W., Simsek M., Zarban S., al-Nakib W. 1990; The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S Ela gene. Archives of Virology 112:67–80
    [Google Scholar]
  35. Paterson T., Everett R. D. 1990; A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. Journal of General Virology 71:1775–1783
    [Google Scholar]
  36. Preston C. M., Frame M. C., Campbell M. E. M. 1988; A complex formed between cell components and a herpes simplex virus structural polypeptide binds to a viral immediate-early gene regulatory DNA sequence. Cell 52:425–434
    [Google Scholar]
  37. Roemer K., Johnson P. A., Friedmann T. 1991; Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175. Journal of Virology 65:6900–6912
    [Google Scholar]
  38. Russell W. C., Patel G., Precious B., Sharp I., Gardner P. S. 1981; Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization. Journal of General Virology 56:393–408
    [Google Scholar]
  39. Sambucetti L. C., Cherrington J. M., Wilkinson G. W. G., Mocarski E. S. 1989; NF-KB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO Journal 13:4251–4258
    [Google Scholar]
  40. Shenk T. 1996; Adenoviridae: the viruses and their replication. In Fundamental Virology, 3rd edn. pp. 979–1016 Fields B. N., Knipe D. M., Howley P. M. Edited by Philadelphia: Lippincott-Raven;
    [Google Scholar]
  41. Shirahata S., Watanabe J., Teruya K., Yano T., Osada K., Ohashi H., Tachibana H., Kim E. H., Murakami H. 1995; E1A and rasoncogenes synergistically enhance recombinant protein production under the control of the cytomegalovirus promoter in BHK-21 cells. Bioscience Biotechnology and Biochemistry 59:345–347
    [Google Scholar]
  42. Sinclair J. H., Baillie J., Taylor-Wiedeman J. A., Sissons J. G. P. 1992; Repression of human cytomegalovirus major immediate early gene-expression in a monocytic cell-line. Journal of General Virology 73:433–435
    [Google Scholar]
  43. Spergel J. M., Chen-Kiang S. 1991; Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proceedings of the National Academy of Sciences, USA 88:6472–6476
    [Google Scholar]
  44. Spessot R., Inchley K., Hupel T. M., Bacchetti S. 1980; Cloning of the herpes-simplex virus ICP4 gene in an adenovirus vector - effects on adenovirus gene-expression and replication. Virology 168:378–387
    [Google Scholar]
  45. Stamminger T., Fickenscher H., Fleckenstein B. 1990; Cell type- specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. Journal ofGeneral Virology 71:105–113
    [Google Scholar]
  46. Stinski M. F., Roehr T. J. 1985; Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific transactivating components. Journal of Virology 55:431–441
    [Google Scholar]
  47. Stow E. C., Stow N. D. 1989; Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. Journal of General Virology 70:695–704
    [Google Scholar]
  48. Thomsen D. R., Stenberg R. M., Goins W. F., Stinski M. F. 1984; Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proceedings of the National Academy of Sciences, USA 81:659–663
    [Google Scholar]
  49. Wilkinson G. W. G., Akrigg A. 1991; The cytomegalovirus major immediate early promoter and its use in eukaryotic expression systems. In Advances in Gene Technology 2 pp. 287–310 Greenaway P. J. Edited by London: JAI Press;
    [Google Scholar]
  50. Wilkinson G. W. G., Akrigg A. 1992; Constitutive and enhanced expression from the CMV major IE-promoter in a defective adenovirus vector. Nucleic Acids Research 20:2233–2239
    [Google Scholar]
  51. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gonczol E., Wilson J. M. 1994; Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proceedings of the National Academy of Sciences, USA 91:4407–4411
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-2-445
Loading
/content/journal/jgv/10.1099/0022-1317-78-2-445
Loading

Data & Media loading...

Most cited Most Cited RSS feed